Literature DB >> 22849268

Antibiotics that affect the ribosome.

T Lambert1.   

Abstract

The ribosome is a major bacterial target for antibiotics. Drugs inhibit ribosome function either by interfering in messenger RNA translation or by blocking the formation of peptide bonds at the peptidyl transferase centre. These effects are the consequence of the binding of drugs to the ribosomal subunits. Various mechanisms, including enzymatic detoxification, target alteration (ribosomal [r]RNAs and ribosomal proteins) and reduced accumulation (impermeability and efflux) are involved in bacterial resistance to protein synthesis inhibitors. The fact that some positions in rRNA participate in the binding of antibiotics belonging to distinct families explains why bacteria have developed mechanisms that can lead to cross-resistance.

Mesh:

Substances:

Year:  2012        PMID: 22849268     DOI: 10.20506/rst.31.1.2095

Source DB:  PubMed          Journal:  Rev Sci Tech        ISSN: 0253-1933            Impact factor:   1.181


  17 in total

1.  Development, antibiotic production, and ribosome assembly in Streptomyces venezuelae are impacted by RNase J and RNase III deletion.

Authors:  Stephanie E Jones; Vivian Leong; Joaquin Ortega; Marie A Elliot
Journal:  J Bacteriol       Date:  2014-09-29       Impact factor: 3.490

Review 2.  Mitochondrial ribosome assembly in health and disease.

Authors:  Dasmanthie De Silva; Ya-Ting Tu; Alexey Amunts; Flavia Fontanesi; Antoni Barrientos
Journal:  Cell Cycle       Date:  2015-06-01       Impact factor: 4.534

3.  Cell-free Determination of Binary Complexes That Comprise Extended Protein-Protein Interaction Networks of Yersinia pestis.

Authors:  Sarah L Keasey; Mohan Natesan; Christine Pugh; Teddy Kamata; Stefan Wuchty; Robert G Ulrich
Journal:  Mol Cell Proteomics       Date:  2016-08-03       Impact factor: 5.911

4.  Identification of cellular and molecular factors determining the response of cancer cells to six ergot alkaloids.

Authors:  Marco Mrusek; Ean-Jeong Seo; Henry Johannes Greten; Michael Simon; Thomas Efferth
Journal:  Invest New Drugs       Date:  2014-10-25       Impact factor: 3.850

Review 5.  Actinomycetes: A Never-Ending Source of Bioactive Compounds-An Overview on Antibiotics Production.

Authors:  Davide De Simeis; Stefano Serra
Journal:  Antibiotics (Basel)       Date:  2021-04-22

Review 6.  tRNAs as antibiotic targets.

Authors:  Shaileja Chopra; John Reader
Journal:  Int J Mol Sci       Date:  2014-12-25       Impact factor: 5.923

7.  Multi-focal control of mitochondrial gene expression by oncogenic MYC provides potential therapeutic targets in cancer.

Authors:  Amanda R Oran; Clare M Adams; Xiao-Yong Zhang; Victoria J Gennaro; Harla K Pfeiffer; Hestia S Mellert; Hans E Seidel; Kirsten Mascioli; Jordan Kaplan; Mahmoud R Gaballa; Chen Shen; Isidore Rigoutsos; Michael P King; Justin L Cotney; Jamie J Arnold; Suresh D Sharma; Ubaldo E Martinez-Outschoorn; Christopher R Vakoc; Lewis A Chodosh; James E Thompson; James E Bradner; Craig E Cameron; Gerald S Shadel; Christine M Eischen; Steven B McMahon
Journal:  Oncotarget       Date:  2016-11-08

Review 8.  The Food Production Environment and the Development of Antimicrobial Resistance in Human Pathogens of Animal Origin.

Authors:  Manjusha Lekshmi; Parvathi Ammini; Sanath Kumar; Manuel F Varela
Journal:  Microorganisms       Date:  2017-03-14

9.  Assessment of antibiotic susceptibility in Lactobacillus isolates from chickens.

Authors:  Marta Dec; Renata Urban-Chmiel; Dagmara Stępień-Pyśniak; Andrzej Wernicki
Journal:  Gut Pathog       Date:  2017-09-19       Impact factor: 4.181

10.  Functional metagenomic approach to identify overlooked antibiotic resistance mutations in bacterial rRNA.

Authors:  Kentaro Miyazaki; Kei Kitahara
Journal:  Sci Rep       Date:  2018-04-03       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.